Variables | Total | sdLDL Q1 | sdLDL Q2 | sdLDL Q3 | sdLDL Q4 | p |
---|---|---|---|---|---|---|
n = 4148 | n = 1036 | n = 1028 | n = 1035 | n = 1049 | ||
Clinical characteristics | ||||||
 Age, years | 59.7 ± 9.8 | 58.4 ± 9.0 | 57.5 ± 8.8 | 56.5 ± 8.8 | 56.0 ± 8.9 | < 0.001 |
 Male, n (%) | 2967 (71.5) | 748 (72.2) | 747 (72.7) | 760 (73.4) | 712 (67.9) | 0.022 |
 BMI (kg/m2) | 26.0 ± 3.1 | 25.5 ± 3.1 | 25.8 ± 3.2 | 26.1 ± 2.9 | 26.5 ± 3.0 | < 0.001 |
 Hypertension, n (%) | 2686 (64.8) | 649 (62.6) | 672 (65.4) | 661 (63.9) | 704 (67.1) | 0.164 |
 Glucose metabolism status, n (%) | 0.001 | |||||
  NGR | 892 (21.5) | 272 (26.3) | 211 (20.5) | 211 (20.4) | 198 (18.9) |  |
  Pre-DM | 1702 (41.0) | 407 (39.3) | 413 (40.2) | 447 (43.2) | 435 (41.5) |  |
  DM | 1554 (37.5) | 357 (34.5) | 404 (39.3) | 377 (36.4) | 416 (39.7) |  |
 Family history of CAD, n (%) | 594 (14.3) | 129 (12.5) | 141 (13.7) | 149 (14.4) | 175 (16.7) | 0.045 |
 Current smoker, n (%) | 2284 (55.1) | 578 (55.8) | 563 (54.8) | 565 (54.6) | 578 (55.1) | 0.95 |
 Drinking, n (%) | 1376 (33.2) | 352 (34.1) | 330 (32.1) | 352 (34.0) | 341 (32.5) | 0.694 |
Laboratory findings | ||||||
 Glucose (mmol/L) | 6.2 ± 2.0 | 5.8 ± 1.7 | 6.2 ± 2.1 | 6.2 ± 2.0 | 6.5 ± 2.2 | < 0.001 |
 HbA1c (%) | 6.5 ± 1.2 | 6.4 ± 1.1 | 6.6 ± 1.3 | 6.5 ± 1.2 | 6.6 ± 1.3 | < 0.001 |
 Creatinine (μmol) | 77.3 ± 15.2 | 77.6 ± 15.9 | 78.2 ± 15.6 | 77.4 ± 15.3 | 76.8 ± 15.6 | 0.544 |
 TC (mmol/L) | 4.12 ± 1.08 | 3.24 ± 0.74 | 3.80 ± 0.69 | 4.22 ± 0.74 | 5.19 ± 1.02 | < 0.001 |
 HDL-C (mmol/L) | 1.05 ± 0.29 | 1.08 ± 0.30 | 1.06 ± 0.30 | 1.02 ± 0.28 | 1.04 ± 0.27 | < 0.001 |
 LDL-C (mmol/L) | 2.50 ± 0.94 | 1.79 ± 0.64 | 2.26 ± 0.59 | 2.62 ± 0.69 | 3.34 ± 1.00 | < 0.001 |
 Non-HDL-C (mmol/L) | 3.07 ± 1.04 | 2.15 ± 0.67 | 2.74 ± 0.59 | 3.20 ± 0.64 | 4.15 ± 0.97 | < 0.001 |
 sdLDL (mg/dL) | 30.18 ± 16.14 | 13.42 ± 3.25 | 22.39 ± 2.36 | 32.20 ± 3.47 | 52.37 ± 13.02 | < 0.001 |
 TG (mmol/L) | 1.50 (1.10–2.12) | 1.07 (0.87–1.33) | 1.37 (1.09–1.74) | 1.67 (1.32–2.19) | 2.24 (1.74–2.98) | < 0.001 |
 Gensini score | 22 (10–38) | 22 (10–37) | 22 (11–36) | 24 (13–38) | 24 (13–41) | 0.047 |
Medications | ||||||
 Statins at baseline, n (%) | 2645 (63.8) | 732 (70.7) | 690 (67.1) | 370 (64.3) | 491 (53.2) | < 0.001 |
 Statins at discharge, n (%) | 3989 (96.2) | 1020 (98.5) | 991 (96.4) | 986 (95.3) | 992 (94.6) | < 0.001 |
 Aspirin at baseline, n (%) | 2505 (60.4) | 617 (59.6) | 601 (58.5) | 633 (61.2) | 654 (62.3) | 0.280 |
 ACEIs/ARBs at baseline, n (%) | 1143 (27.6) | 271 (26.2) | 297 (28.9) | 293 (28.3) | 282 (26.9) | 0.482 |
 β-blockers at baseline, n (%) | 2202 (53.1) | 551 (53.2) | 542 (52.7) | 562 (54.3) | 547 (52.1) | 0.333 |
 Antidiabetic drugs at baseline | ||||||
  OADs, n (%) | 815 (19.6) | 217 (20.9) | 192 (18.7) | 185 (17.9) | 223 (21.1) | 0.163 |
  Insulin, n (%) | 462 (11.1) | 122 (11.8) | 100 (9.7) | 126 (12.2) | 114 (10.9) | 0.297 |